This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
Biotechnology firm eGenesis, in Cambridge, Massachusetts, received approval from the US Food and Drug Administration in December 2024 for three pig kidney xenotransplantations under a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results